FDA Drug Application (021055) for TARGRETIN by VALEANT LUXEMBOURG

Back to FDA Applications sponsored by VALEANT LUXEMBOURG

Application Number021055
Product Number001
FormCAPSULE;ORAL
Dosage75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTARGRETIN
Active IngredientBEXAROTENE

Active IngredientCount
List of drugs with Active Ingredient BEXAROTENE2


Back to FDA Applications sponsored by VALEANT LUXEMBOURG